Are you heading to the AACR annual meeting 2026? Reddot Biotech is excited to connect with oncology researchers and share high-quality tools that help drive meaningful progress in cancer studies. Whether you’re exploring tumor biology, engineered immunotherapy and CAR-T responses, cell death pathways, or immune checkpoint mechanisms, our ELISA kits, assay kits, and antibodies deliver the consistent, reproducible results your research demands.
Our Houston headquarters team will be on-site and happy to discuss your analytical needs and current projects.
Our products are optimized for the needs of modern cancer research—offering fast protocols, high sensitivity, and excellent performance across human and mouse models. Here are some of our most relevant product categories for advancing your assays:
Critical for studying programmed cell death in cancer cells and therapy response mechanisms.
Ideal for analyzing inflammation, immune signaling, and quantifying critical targets like IL-6, IFN-gamma, and TNF-alpha in the tumor microenvironment.
High-specificity antibodies targeting key markers in tumor proliferation, immune checkpoints, and therapy response.
Uncover metabolic reprogramming and phenomena like the Warburg effect in cancer cells.
All of these products—and thousands more—are available in our full product catalog. You can also explore our complete antibodies collection and comprehensive ELISA kits online.
Ready to advance your cancer research?
Stop by Booth 1652 at AACR 2026 to speak with the Reddot Biotech team, or discuss how our tools can support your specific projects.
Looking forward to seeing you in San Diego!
Reddot Biotech – Reliable reagents for breakthrough discoveries in cancer research.
